The purpose of the study was to determine the differences between aflibercept and ranibizumab in terms of their therapeutic efficacy in the treatment of Type 3 neovascularisation. The authors highlight that the dominant mechanism for Type 3 neovascularisation development is...
The overall goal of the Global Vision Database (GVD) [1] is to develop and deploy new and improved evidence on the prevalence of blindness and vision impairment (VI) globally. It is a repository which allows us to assess the causes...
If you are in your final year of medicine at university, firstly congratulations on making it so far and secondly, you may be wondering how and which jobs to rank highly. If you have found yourself reading this article, then...
In the UK, 100,000 new strokes occur each year, with 1.3 million stroke survivors [1]. This article will focus on post-stroke visual impairment, discussing topics of how common it is, how it can be detected, possible management options and how...
Safa Elhassan gives a brief review of amniotic membrane grafts and their application in theatre and clinic-based settings. Amniotic membrane (AM) transplant has been an established adjuvant treatment for many corneal, conjunctival and scleral disorders in ophthalmic clinical practice with...
The theme of the Scottish Ophthalmological Club spring meeting on 23 September is ‘Post COVID – The Best of Times and The Worst of Times', featuring eminent speakers on a range of topics.
CHEC announces national online CPD event covering critical eye condition that has seen 400% increase in secondary care referrals. The seminar is to be hosted by CHEC Clinical Director Mahmoud Rabie and follows the UK rollout of CHEC’s ground-breaking YAG Quantel Capsulo Laser System which significantly improves accuracy in eye treatments.
Making a five-year plan for an optical or ophthalmology business is uppermost in OSA members’ minds as they look for the best means of supporting the profession at 100% Optical.
The SCONe project, run by optometrists, ophthalmologists, and researchers from the University of Edinburgh, and funded by Sight Scotland, is appealing for participants to take part in a Patient and Public Involvement (PPI) group focused on revolutionising the detection and management of Age-Related Macular Degeneration (AMD).
This review of the Vision Buddy system continues our recent series on wearable assistive technology. The main component of the Vision Buddy system is a VR-type headset, designed to assist users with a range of tasks primarily within the home...
This is the second part of the review of the Envision Glasses (see Part 1 here), a wearable piece of assistive technology. Features From the main menu four feature modes can be chosen: Read, Identify, Find and Call. The Glasses...